The ARN Clinical Research unit is equipped well to deploy new clinical research models. Credit: ibbl.

American Rheumatology Network (ARN) has launched ARN Clinical Research, a patient centric and real-world technology unit for transforming rheumatology trials and care.

The new unit will be dedicated to transforming drug development efforts in rheumatology research in collaboration with real-world technology solutions provider Trio Health.

ARN Clinical Research will bring together the power of the ARN network with Trio’s data management technologies to develop an integrated clinical research ecosystem.

Through this ecosystem, manufactures will be able to achieve their goals for delivering patient-centric treatment approaches that would be in line with existing unmet needs.

ARN CEO Michael Cooper said: “The launch of this dedicated unit builds on ARN’s long standing commitment and history in community rheumatology and clinical research.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“By tapping into the largest rheumatology network in the US, ARN Clinical Research has amassed a set of game-changing capabilities to support manufacturers’ drug development efforts in the fight to transform rheumatologic diseases.”

ARN Clinical Research has direct connection to the rheumatology practices integrated through its MDX Platform that gives manufactures access to more than 35 physician practices and real-time patient experiences.

Manufacturers will get a clear view for the patient symptomatic therapy to support clinical strategy and clinical trial execution for introducing new and targeted treatment options with different mechanisms of action to patients.

The centralised ARN Clinical Research unit is better equipped to deploy new clinical research models including decentralised and hybrid trials, pragmatic trials, and synthetic arms.

The services delivered by ARN Clinical Research will support the complete product lifecycle, including physician advisory boards, rapid start up for clinical trials, patient recruitment, and data management.